Filing Details
- Accession Number:
- 0001209191-22-016447
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-04 18:05:25
- Reporting Period:
- 2022-03-02
- Accepted Time:
- 2022-03-04 18:05:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1567514 | Intra-Cellular Therapies Inc. | ITCI | Pharmaceutical Preparations (2834) | 364742850 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1829958 | K. Suresh Durgam | C/O Intra-Cellular Therapies, Inc. 430 East 29Th Street New York NY 10016 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-03-02 | 4,177 | $56.98 | 26,964 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-03-04 | 3,860 | $55.52 | 23,104 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in 2021.
Billionaire Hedge Funds
